Previously, DMF was used to treat autoimmune diseases, like multiple sclerosis and psoriasis, probably involving covalent modifications through Michael addition by cysteine residues, namely Nrf2 (Nuclear factor erythroid-derived 2-like 2) with a consequent anti-oxidant response [54]. Here, NFE2L2 is linked to autoimmune disease.